Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study

Yoshiya Tanaka, Hisashi Yamanaka, Naoki Ishiguro, Nobuyuki Miyasaka, Katsuyoshi Kawana, Katsutoshi Hiramatsu, Tsutomu Takeuchi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Fingerprint Dive into the research topics of 'Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences